Literature DB >> 32424701

FAM83H overexpression predicts worse prognosis and correlates with less CD8+ T cells infiltration and Ras-PI3K-Akt-mTOR signaling pathway in pancreatic cancer.

H Zhuang1,2, C Zhang3, B Hou4.   

Abstract

BACKGROUND: Family with sequence similarity 83 members H (FAM83H) is one member of Family with sequence similarity 83 (FAM83) family, which possess oncogenic properties in several types of cancer. However, the potential function of FAM83H in pancreatic cancer (PC) still remain unknown. AIM: This study aims to explore the role of FAM83H during pancreatic carcinogenesis and the regulation of immune infiltration in PC.
METHODS: In the current study, the clinical significance and potential biological of FAM83H were evaluated by bioinformatics analysis. Possible associations between FAM83H expression and tumor immunity were analyzed using ESTIMATE algorithm and single-sample gene set enrichment analysis (ssGSEA).
RESULTS: FAM83H expression was significantly upregulated in tumor tissues, and positively associated with higher histologic grade, tumor recurrence, and worse prognosis. FAM83H overexpression is notably associated with KRAS activation. And functional enrichment analysis demonstrated that FAM83H may be involved in positive regulation of cell proliferation and migration, Ras protein signal transduction, regulation of cell-matrix adhesion, epithelial to mesenchymal transition (EMT), TGF-β receptor signaling in EMT, and activated NOTCH transmits signal to the nucleus. ESTIMATE algorithm and ssGSEA demonstrated that FAM83H overexpression suppressed the infiltration and antitumor activity of tumor-infiltrating lymphocytes (TILs), especially for CD8+ T cells. Besides, FAM83H overexpression significantly correlated with low expression of TIL-related gene markers (e.g. CD8A, CD8B, CD2, CD3D, and CD3E).
CONCLUSION: The study suggests that FAM83H overexpression predicts poor prognosis and correlates with less CD8+ T cells infiltration and Ras-PI3K-Akt-mTOR signaling pathway in PC.

Entities:  

Keywords:  CD8+ T cells; FAM83H; NOTCH1; Pancreatic cancer; RAS-PI3K-Akt-mTOR; TGF-β

Mesh:

Substances:

Year:  2020        PMID: 32424701     DOI: 10.1007/s12094-020-02365-z

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  11 in total

1.  An immune-related model based on INHBA, JAG2 and CCL19 to predict the prognoses of colon cancer patients.

Authors:  Xuankun Yang; Jia Yan; Yahui Jiang; Yaxu Wang
Journal:  Cancer Cell Int       Date:  2021-06-08       Impact factor: 5.722

2.  B3GNT3 overexpression promotes tumor progression and inhibits infiltration of CD8+ T cells in pancreatic cancer.

Authors:  Hongkai Zhuang; Zixuan Zhou; Zedan Zhang; Xinming Chen; Zuyi Ma; Shanzhou Huang; Yuanfeng Gong; Chuanzhao Zhang; Baohua Hou
Journal:  Aging (Albany NY)       Date:  2020-12-09       Impact factor: 5.682

3.  Establishment of a Macrophage Phenotypic Switch Related Prognostic Signature in Patients With Pancreatic Cancer.

Authors:  Mu-Xing Li; Hang-Yan Wang; Chun-Hui Yuan; Zhao-Lai Ma; Bin Jiang; Lei Li; Li Zhang; Dian-Rong Xiu
Journal:  Front Oncol       Date:  2021-03-03       Impact factor: 6.244

4.  Identification of Prognostic Biomarkers Among FAM83 Family Genes in Human Ovarian Cancer Through Bioinformatic Analysis and Experimental Verification.

Authors:  Shaochong Lin; Junpeng Du; Jun Hao; Xiaohua Luo; Han Wu; Huifang Zhang; Xinxin Zhao; Lida Xu; BaoJin Wang
Journal:  Cancer Manag Res       Date:  2021-11-15       Impact factor: 3.989

5.  FAM83H and Nectin1 expression are related with survival and relapse of bladder urothelial carcinoma patients.

Authors:  Ae-Ri Ahn; Sang Jae Noh; Usama Khamis Hussein; Ho Sung Park; Myoung Ja Chung; Ho Lee; Woo Sung Moon; Myoung Jae Kang; Hyung Jin Kim; Na Ri Lee; Kyu Yun Jang; Kyoung Min Kim
Journal:  BMC Urol       Date:  2021-10-08       Impact factor: 2.264

6.  An immune-related gene prognostic risk index for pancreatic adenocarcinoma.

Authors:  Yang Su; Ruoshan Qi; Lanying Li; Xu Wang; Sijin Li; Xuan Zhao; Rui Hou; Wen Ma; Dan Liu; Junnian Zheng; Ming Shi
Journal:  Front Immunol       Date:  2022-07-26       Impact factor: 8.786

7.  Pan-cancer analysis of the FAM83 family and its association with prognosis and tumor microenvironment.

Authors:  Shangkun Yuan; Zhisheng Huang; Xiaoying Qian; Yong Wang; Chen Fang; Renfang Chen; Xinwei Zhang; Zhehao Xiao; Qian Wang; Biao Yu; Yong Li
Journal:  Front Genet       Date:  2022-07-22       Impact factor: 4.772

8.  5mC and H3K9me3 of TRAF3IP2 promoter region accelerates the progression of translocation renal cell carcinoma.

Authors:  Lei Yang; Yi Chen; Ning Liu; Yanwen Lu; Xin Li; Wenliang Ma; Weidong Gan; Dongmei Li
Journal:  Biomark Res       Date:  2022-07-27

9.  Identification of LIPH as an unfavorable biomarkers correlated with immune suppression or evasion in pancreatic cancer based on RNA-seq.

Authors:  Hongkai Zhuang; Xinming Chen; Ying Wang; Shanzhou Huang; Bo Chen; Chuanzhao Zhang; Baohua Hou
Journal:  Cancer Immunol Immunother       Date:  2021-07-19       Impact factor: 6.968

10.  Identification of immune-infiltrating cell-related biomarkers in hepatocellular carcinoma based on gene co-expression network analysis.

Authors:  Yinghui Hou; Guizhi Zhang
Journal:  Diagn Pathol       Date:  2021-07-04       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.